官方服务：
资源简介：
CEA and cost analysis of integrative oncology therapy in stage IV NSCLC patients
应用场景：
创建时间：
2020-02-05
相关数据集
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against NSCLC
Network pharmacology analysis data, including analysis process and results.
科学数据银行2022-06-21 更新40
DataSheet13_Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer.zip
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are emerging at the vanguard of therapy for non-small-cell lung cancer (NSCLC) patients with EGFR-activating mutations. Howeve
NIAID Data Ecosystem20
Data Sheet 1_Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer.zip
IntroductionTumor angiogenesis is required for the progression of non-small cell lung cancer (NSCLC), and anti-vascular endothelial growth factor (anti-VEGF) antibody bevacizumab and multitarget tyros
NIAID Data Ecosystem00
Studies included in the meta-analysis.
Abbreviations: MLND, mediastinal lymph node dissection; MLNS, mediastinal lymph node sampling; NSCLC, non-small cell lung cancer; ND, not derived.Studies included in the meta-analysis.
Figshare2015-12-02 更新40
Themes, subthemes and representative quotes of medication experience of patients with non-small cell lung cancer using oral targeted therapy.
Themes, subthemes and representative quotes of medication experience of patients with non-small cell lung cancer using oral targeted therapy.
Figshare2023-05-30 更新10
